Artículos por temáticas

The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice

Pinho BR, Duarte AI, Canas PM, Moreira PI, Murphy MP, Oliveira JMA.

Free Radic Biol Med. 2020 Jan;146:372-382. doi: 10.1016/j.freeradbiomed.2019.11.021. Epub 2019 Nov 18.

Could metformin be therapeutically useful in Huntington's disease?

Tang BL.

Rev Neurosci. 2020 Apr 28;31(3):297-317. doi: 10.1515/revneuro-2019-0072.

Overt Hypogonadism May Not Be a Sentinel Sign of RING Finger Protein 216: Two Novel Mutations Associated with Ataxia, Chorea, and Fertility.

Lieto M, Galatolo D, Roca A, Cocozza S, Pontillo G, Fico T, Pane C, Saccà F, De Michele G, Santorelli FM, Filla A.

Mov Disord Clin Pract. 2019 Oct 23;6(8):724-726. doi: 10.1002/mdc3.12839. eCollection 2019 Nov. No abstract available.

Huntington's chorea, a neurological disorder of all ages - Bioinformatics approach for its precise diagnosis.

Srirama K, Vineela J, Tejaswi K, Thanmayi MN.

Int J Health Sci (Qassim). 2019 Nov-Dec;13(6):26-30.

Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington's disease.

Yildirim F, Ng CW, Kappes V, Ehrenberger T, Rigby SK, Stivanello V, Gipson TA, Soltis AR, Vanhoutte P, Caboche J, Housman DE, Fraenkel E.

Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24840-24851. doi: 10.1073/pnas.1908113116. Epub 2019 Nov 19.

Abnormal Photic Entrainment to Phase-Delaying Stimuli in the R6/2 Mouse Model of Huntington's Disease, despite Retinal Responsiveness to Light.

Ouk K, Aungier J, Ware M, Morton AJ.

eNeuro. 2019 Dec 10;6(6). pii: ENEURO.0088-19.2019. doi: 10.1523/ENEURO.0088-19.2019. Print 2019 Nov/Dec.

Duty of care versus patient confidentiality: High Court hears test case on Huntington's disease.

Dyer C.

BMJ. 2019 Nov 19;367:l6600. doi: 10.1136/bmj.l6600. No abstract available.

Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.

Carlozzi NE, Boileau NR, Hahn EA, Barton SK, Cella D, McCormack MK, Ready RE.

J Huntingtons Dis. 2019 Nov 11. doi: 10.3233/JHD-190385. [Epub ahead of print]

A Systematic Review of Rehabilitation for Corticobulbar Symptoms in Adults with Huntington's Disease.

Burnip E, Wallace E, Gozdzikowska K, Huckabee ML.

J Huntingtons Dis. 2019 Nov 11. doi: 10.3233/JHD-190384. [Epub ahead of print]

Role of Phosphorylated Tau and Glucose Synthase Kinase 3 Beta in Huntington's Disease Progression.

Sawant N, Reddy PH.

J Alzheimers Dis. 2019 Nov 13. doi: 10.3233/JAD-190851. [Epub ahead of print]

Brain compensation during visuospatial working memory in premanifest Huntington's disease.

Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou-Karistianis N.

Neuropsychologia. 2019 Nov 14;136:107262. doi: 10.1016/j.neuropsychologia.2019.107262. [Epub ahead of print]

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model

Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS.

Neurotherapeutics. 2020 Jan;17(1):252-268. doi: 10.1007/s13311-019-00805-5.

Discovery of a potent small molecule inhibiting Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein.

Khan E, Mishra SK, Mishra R, Mishra A, Kumar A.

Sci Rep. 2019 Nov 14;9(1):16872. doi: 10.1038/s41598-019-53410-z.

Association Between Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease

Vuono R, Kouli A, Legault EM, Chagnon L, Allinson KS, La Spada A; REGISTRY Investigators of the European Huntington's Disease Network, Biunno I, Barker RA, Drouin-Ouellet J.

Mov Disord. 2020 Mar;35(3):401-408. doi: 10.1002/mds.27911. Epub 2019 Nov 14.

HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease

Carlozzi NE, Boileau NR, Chou KL, Ready RE, Cella D, McCormack MK, Miner JA, Dayalu P.

Mov Disord. 2020 Feb;35(2):326-336. doi: 10.1002/mds.27908. Epub 2019 Nov 14.